XML 31 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaboration and License Agreements (Tables)
 9 Months Ended
Sep. 30, 2016
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):  

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2016

 

 

2015

 

 

2016

 

 

2015

 

BMS and Pfizer

 

$

1,798

 

 

$

388

 

 

$

4,785

 

 

$

1,152

 

Daiichi Sankyo

 

 

3,810

 

 

 

1,154

 

 

 

8,491

 

 

 

3,424

 

Bayer and Janssen

 

 

3,316

 

 

 

1,316

 

 

 

7,431

 

 

 

2,922

 

Bayer

 

 

398

 

 

 

—

 

 

 

1,052

 

 

 

—

 

Lee’s Pharmaceutical

 

 

—

 

 

 

54

 

 

 

52

 

 

 

158

 

Total collaboration and license revenue

 

$

9,322

 

 

$

2,912

 

 

$

21,811

 

 

$

7,656